首页> 外文期刊>Alternatives to laboratory animals: ATLA >Animal Research for Type 2 Diabetes Mellitus, Its Limited Translation for Clinical Benefit,and the Way Forward
【24h】

Animal Research for Type 2 Diabetes Mellitus, Its Limited Translation for Clinical Benefit,and the Way Forward

机译:2型糖尿病的动物研究,其对临床效益的有限翻译,以及前进的方式

获取原文
获取原文并翻译 | 示例
       

摘要

Obesity and type 2 diabetes mellitus (T2DM) have reached pandemic proportions worldwide, and considerable research efforts have been dedicated to investigating disease pathology and therapeutic options. The two hallmark features of T2DM, insulin resistance and pancreatic dysfunction, have been studied extensively by using various animal models. Despite the knowledge acquired from such models, particularly mechanistic discoveries that sometimes mimic human T2DM mechanisms or pathways, many details of human T2DM pathogenesis remain unknown, therapeutic options remain limited, and a cure has eluded research. Emerging human data have raised concern regarding inter-species differences at many levels (e.g. in gene regulation, pancreatic cytoarchitecture, glucose transport, and insulin secretion regulation), and the subsequent impact of these differences on the clinical translation of animal research findings. Therefore, it is important to recognise and address the translational gap between basic animal-based research and the clinical advances needed to prevent and treat T2DM. The purpose of this report is to identify some limitations of T2DM animal research, and to propose how greater human relevance and applicability of hypothesis-driven basic T2DM research could be achieved through the use of human-based data acquisition at various biological levels. This report addresses how in vitro, in vivo and in silico technologies could be used to investigate particular aspects of human glucose regulation. We do not propose that T2DM animal research has been without value in the identification of mechanisms, pathways, or potential targets for therapies, nor do we claim that human-based methods can provide all the answers. We recognise that the ultimate goal of T2DM animal research is to identify ways to advance the prevention, recognition and treatment of T2DM in humans, but postulate that this is where the use of animal models falls short, despite decades of effort. The best way to achieve this goal is by prioritising human-centred research.
机译:肥胖症和2型糖尿病(T2DM)达到了全球大流行的比例,并致力于调查疾病病理和治疗方案的大量研究努力。通过使用各种动物模型,已经通过各种Anims模型进行了T2DM,胰岛素抵抗和胰腺功能障碍的两个标志特征。尽管从这些模型中获得的知识,但特别是机械发现有时是模拟人类T2DM机制或途径,但人类T2DM发病机制的许多细节仍然是未知的,治疗选项仍然有限,并且治愈的研究已经存在研究。新兴人类数据对物种间差异有关许多级别(例如,在基因调节,胰腺细胞建筑,葡萄糖分泌调控中),以及随后对这些差异对动物研究结果临床翻译的影响。因此,重要的是要识别并解决基于基于动物的基础研究之间的平移差距以及预防和治疗T2DM所需的临床进步。本报告的目的是确定T2DM动物研究的一些局限性,并提出通过在各种生物学水平的人的数据采集中使用基于人的数据采集来实现假设驱动的基本T2DM研究的更大人类相关性和适用性。本报告解决了体内的体外,体内和硅技术可用于调查人类葡萄糖调节的特定方面。我们不提出T2DM动物研究在识别机制,途径或疗法的潜在目标方面没有价值,也没有要求我们基于人类的方法可以提供所有答案。我们认识到,T2DM动物研究的最终目标是识别推进人类T2DM的预防,识别和治疗的方法,但假设这就是动物模型的使用短缺,尽管数十年的努力。实现这一目标的最佳方法是优先考虑以人为本的研究。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号